The expression of lncRNA-LINC00173 is reduced in non-small cell lung cancer, causing miRNA-182 to aggregate and inhibit the Advanced Glycosylation End-Product Specific Receptor (AGER) / nuclear factor kappa-B (NF-κB) pathway, promoting tumor growth and metastasis [61]. The gene discussed is NFKB1; the disease is neoplasm.